Extend Biosciences is Awarded a START Grant from MassVentures
Extend Biosciences’ EXT608 for hypoparathyroidism receives additional support from MassVentures’ START program, which helps growing Massachusetts-based companies convert research developed under SBIR and STTR contracts into businesses and jobs in Massachusetts.